Member Exclusive

The Regulation of Clinical Stem Cell Research and Applications: three dynamics of global regulatory diversification (part 3)

In the third and final part of this commentary, Achim Rosemann provides thoughts on abandoning of the multiphase trial system and his concluding remarks.

Go to the profile of RegMedNet
Jun 19, 2017

Please sign in or register for FREE

No comments yet.